1,2-Dichloroethane → HCID 59375005, 화합물
반응식
[C:1]([C:4]1[CH:5]=[CH:6][C:7]([C:20]2[CH:25]=[CH:24][CH:23]=[CH:22][C:21]=2[F:26])=[C:8]2[C:16]=1[NH:15][C:14]1[CH:13]=[C:12]([C:17](O)=[O:18])[CH:11]=[CH:10][C:9]2=1)(=[O:3])[NH2:2].C(Cl)CCl.C1C=CC2N(O)N=NC=2C=1.CCN(C(C)C)C(C)C.[CH3:50][N:51]1[CH2:56][CH2:55][CH:54]([NH2:57])[CH2:53][CH2:52]1>C1COCC1.CN(C=O)C>[F:26][C:21]1[CH:22]=[CH:23][CH:24]=[CH:25][C:20]=1[C:7]1[C:8]2[C:9]3[C:14](=[CH:13][C:12]([C:17]([NH:57][CH:54]4[CH2:55][CH2:56][N:51]([CH3:50])[CH2:52][CH2:53]4)=[O:18])=[CH:11][CH:10]=3)[NH:15][C:16]=2[C:4]([C:1]([NH2:2])=[O:3])=[CH:5][CH:6]=1참가 물질
실험 절차
A mixture of 8-carbamoyl-5-(2-fluorophenyl)-9H-carbazole-2-carboxylic acid (Example 23-2, 30 mg, 0.086 mmol), EDC (23.11 mg, 0.121 mmol), HOBT (18.46 mg, 0.121 mmol), DIEA (30 μL, 0.172 mmol), and 1-methylpiperidin-4-amine (9.83 mg, 0.086 mmol) in THF and DMF (4:1, 2 mL) was stirred at rt overnight. The mixture was concentrated and purified by preparative HPLC. The isolated product was partitioned between DCM and NaHCO3 (aq). The organic phase was dried and concentrated to provide 4-(2-fluorophenyl)-N7-(1-methylpiperidin-4-yl)-9H-carbazole-1,7-dicarboxamide as a white solid (25 mg, 62%). 1H NMR (400 MHz, DMSO-d6) δ 11.75 (s, 1 H) 8.24 (br. s., 1 H) 8.20 (s, 1 H) 8.13 (d, J=7.69 Hz, 1 H) 8.05 (d, J=7.91 Hz, 1 H) 7.52-7.68 (m, 3 H) 7.33-7.48 (m, 3 H) 7.13 (d, J=7.69 Hz, 1 H) 7.05 (d, J=8.35 Hz, 1 H) 3.64-3.80 (m, 1 H) 2.69-2.79 (m, 2 H) 1.87-2.00 (m, 2 H) 1.70-1.80 (m, 2 H) 1.48-1.65 (m, 2 H). Mass spectrum m/z 445.2 (M+H)+.
후처리
- concentrationThe mixture was concentrated
- custompurified by preparative HPLC
- customThe isolated product was partitioned between DCM and NaHCO3 (aq)
- customThe organic phase was dried
- concentrationconcentrated
출처 및 근거
- ORD 기록
- ord-0016ae49616d4448a3e23bc7e620c50f
- 출처 데이터셋
- uspto-grants-2013_01
- 특허 번호
- US08362065B2
반응 노트
불러오는 중…